REG - Ilika plc - Stereax Manufacturing Update
RNS Number : 5202JIlika plc24 August 2021Ilika plc
("Ilika" or the "Company")
Stereaxâ Manufacturing Update
Ilika (AIM: IKA), a pioneer in solid-state battery technology, provides an update on progress towards implementing Ilika's Stereax manufacturing plans.
Ilika's prime contractor has successfully completed the construction of Ilika's 340 m2 cleanroom at its 1600m2 Stereax manufacturing facility and has now handed over site control to Ilika's operational team. The key deposition tools, previously referred to as "Tool 1" and "Tool 2", as well as the principal etching equipment, have completed their factory acceptance tests and have been delivered to site for facilitisation prior to the start of site acceptance testing and the commencement of process qualification.
Process qualification will continue through Q4 2021, with product qualification expected to take place in Q1 2022, supporting the commencement of product sales from Q2 2022.
Recruitment of the Stereax manufacturing team leaders has been completed, under the leadership of Paul Marron, Ilika's Technology Transfer and Manufacturing Director.
Ilika continues to engage with its portfolio of customers from the Industrial IoT and medical device sectors, including through the provision of Stereax samples from Ilika's pilot line.
Ilika's CEO Graeme Purdy, stated: "Progress on site has been very gratifying to see over the summer and, despite significant global disruption to supply chains, the Ilika team, our vendors and suppliers have worked very hard to deliver our planned project implementation schedule."
For more information contact:
Ilika plc
Graeme Purdy, Chief Executive
Via Walbrook PR
Steve Boydell, Finance Director
Liberum Capital Limited
Tel: 020 3100 2000
Andrew Godber, Cameron Duncan, William Hall, Nikhil Varghese
Walbrook PR Ltd
Tel: 020 7933 8780 / Ilika@walbrookpr.com
Tom Cooper
Mob: 0797 122 1972
Lianne Cawthorne
Mob: 07584 391 303
Nick Rome
Mob: 07748 325 236
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDUPDPPUUWRUPGGQW
Recent news on Ilika
See all newsREG - Ilika plc - Trading Update, Notice of Results & Presentations
AnnouncementREG - Ilika plc - Posting of Circular & Notice of General Meeting
AnnouncementREG - Ilika plc - Result of Placing
AnnouncementREG - Ilika plc - Proposed Placing and Open Offer & Notice of GM
AnnouncementREG - Ilika plc - Agratas joins Goliath industrialisation programme
Announcement